Skip to content

Novel germline JAK2 mutation linked to progression to MF in MPN
Andrew Kuykendall, MD, discusses updated data from the RALLY-MF trial
ERNEST-3 analysis characterizes prevalence of cytopenic MF and treatment trends
Study identifies 4 clinically distinct myelofibrosis subtypes that have different survival prognoses
Study identifies new standard of care for relapsed or refractory MM in the second line and beyond

Insider Reader Survey

Join SOHO

Follow Us :

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

Kami Maddocks, MD

Cellular Therapy

Kami Maddocks, MD

Leukemia

Kami Maddocks, MD

Lymphoma

Kami Maddocks, MD

Multiple Myeloma

Kami Maddocks, MD

Myelodysplastic Syndromes

Kami Maddocks, MD

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

June 17, 2026

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

SOHO Insider Kami Maddocks, MD

Kami Maddocks, MD

by sohonews
October 16, 2024
0 Comments
Less than a minute
662 Views
2 years ago

Share This Post:

Facebook Twitter Pinterest Whatsapp Cloud StumbleUpon Print Share via Email

Related Post

Young scientists conducting research investigations in a medical laboratory, a researcher in the foreground is using a microscope

EHA 2026, Meetings / Conferences, Myeloproliferative Neoplasms, Primary Myelofibrosis

Novel germline JAK2 mutation linked to progression to MF in MPN

June 16, 2026

ASCO 2026, Meetings / Conferences, Myeloproliferative Neoplasms, Primary Myelofibrosis, Video Interviews

Andrew Kuykendall, MD, discusses updated data from the RALLY-MF trial

June 16, 2026

EHA 2026, Meetings / Conferences, Myeloproliferative Neoplasms, Primary Myelofibrosis

ERNEST-3 analysis characterizes prevalence of cytopenic MF and treatment trends

June 16, 2026

Doctor holding an ipad

EHA 2026, Trending now, Myeloproliferative Neoplasms, Primary Myelofibrosis

Study identifies 4 clinically distinct myelofibrosis subtypes that have different survival prognoses

June 14, 2026

EHA 2026, Meetings / Conferences, Multiple Myeloma

Study identifies new standard of care for relapsed or refractory MM in the second line and beyond

June 13, 2026

EHA 2026, ASCO 2026, Meetings / Conferences, Myeloproliferative Neoplasms

Patients with myelofibrosis and anemia respond to antihemojuvelin drug

June 12, 2026

Top Categories

Cellular Therapy

74

Leukemia

113

Lymphoma

128

Multiple Myeloma

98

Myelodysplastic Syndromes

39

Myeloproliferative Neoplasms

28

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

Kami Maddocks, MD

Cellular Therapy

Kami Maddocks, MD

Leukemia

Kami Maddocks, MD

Lymphoma

Kami Maddocks, MD

Multiple Myeloma

Kami Maddocks, MD

Myelodysplastic Syndromes

Kami Maddocks, MD

Myeloproliferative Neoplasms

Subscribe

Recent Posts

Young scientists conducting research investigations in a medical laboratory, a researcher in the foreground is using a microscope

Novel germline JAK2 mutation linked to progression to MF in MPN

Andrew Kuykendall, MD, discusses updated data from the RALLY-MF trial

ERNEST-3 analysis characterizes prevalence of cytopenic MF and treatment trends

Copyright © 2026 Society of Hematologic Oncology, All rights reserved.